Ex Parte No Data - Page 22

                Appeal 2007-1366                                                                              
                Application 90/005,090                                                                        
           1    attached to the Declaration in the official PTO record and an Exhibit 3 was                   
           2    not located in a review of that record.8  Based upon the record before us,                    
           3    Patentee failed to prove unexpected results.                                                  
           4          In any event, taking the declaration statements in ¶ 9 at face value, the               
           5    declaration does not establish that the materials were comparable and                         
           6    differed only in the cross-linking agent.  To show unexpected results,  a                     
           7    comparison of the invention with the prior art must be under identical                        
           8    conditions except for the novel features of the invention.  In re Brown,                      
           9    459 F.2d 531, 173 USPQ 685 (CCPA 1972).                                                       
          10          Patentee also relies on ¶¶ 8-10 of the Neefe declaration to show                        
          11    commercial success, long felt need and copying by others.  Reply Brief in                     
          12    Response to Supplemental Examiner’s Answer filed September 9, 2005,                           
          13    p. 3, p. 20.                                                                                  
          14          Secondary considerations such as commercial success, long felt need,                    
          15    and copying by others, while relevant to the obviousness inquiry, must be                     
          16    proved with clear and convincing evidence. Snow, 471 F.2d at 1404,                            
          17    176 USPQ at 331; Miegel, 404 F.2d at 381, 159 USPQ at 717; Heyna,                             
          18    360 F.2d at 228, 149 USPQ at 697; Lohr, 317 F.2d at 388, 137 USPQ at                          
          19    550-551.  Patentee has provided only conclusory statements. With respect to                   
          20    commercial success, Patentee has not provided evidence of actual sales,                       
          21    market share, growth in market share, replacing earlier units sold by others                  
          22    or of dollar amounts, and no evidence of a nexus between sales and the                        
                                                                                                             
                8  There appears to be three documents attached to the declaration.  The                      
                documents marked Exhibit 1 and Exhibit 2 are single page documents                            
                showing reproductions of chemical structure models.  The third document is                    
                titled “Declaration of Sutton under 37 CFR § 1.132.”  The relevance of this                   
                document to the appeal is not readily apparent.                                               

                                                    - 22 -                                                    

Page:  Previous  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  Next

Last modified: September 9, 2013